SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharmaceuticals informs about trading window closure

30 Jun 2025 Evaluate
Pharmaids Pharmaceuticals has informed that the Trading Window for the Designated Persons and their Immediate relatives dealing in the Securities of the Company will be closed from July 01, 2025 till 48 hours after the declaration of Unaudited Financial Results of the Company for the Quarter ended June 30, 2025. The date of the Board Meeting for consideration of the Unaudited Financial Results of the Company for the Quarter ended 30 th June 2025 shall be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

Pharmaids Pharma Share Price

30.92 -0.49 (-1.56%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×